CME Satellite Symposium

A CME Symposium during the 2026 Heart Failure Management Conference in Fernandina Beach, Florida.

AGENDA

12:30 PM                       Introduction
                                      Mathew Maurer, MD (Chair)

12:35 PM                      Suspecting and Diagnosing Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
                                      Jan Griffin, MD

12:50 PM                      Best Practices for Managing Patients with HF and ATTR-CM
                                      Mathew Maurer, MD

1:10 PM                         Individualized Management of the ATTR-CM Patient with HF
                                      Case Presenter: Frederick Ruberg, MD
                                      Panelists: Jan Griffin, MD; Mathew Maurer, MD

1:25 PM                        Question and Answer

EDUCATIONAL OBJECTIVES

- Recognize the cardiac and extracardiac red fl ags which raise suspicion for ATTR-CM.

- Describe the diagnostic testing components to quickly and accurately diagnose ATTR-CM.

- Summarize current recommendations for use of HF GDMT in ATTR-CM patients and the evolving evidence for Silencers and Stabilizers for ATTR-CM.

- Identify the recommended parameters for monitoring disease progression in ATTR-CM.

Educational Grant

This activity is supported by an independent educational grant from Alnylam Pharmaceuticals, Inc. and BridgeBio.

CHAIR

Mathew Maurer, MD
Arnold and Arlene Goldstein Professor of Cardiology
Professor of Medicine
Columbia University Irving Medical Center
Vagelos College of Physicians & Surgeons
New York, New York

FACULTY

Jan Griffin, MD
Associate Professor of Medicine
Medical University of South Carolina
Charleston, South Carolina

Frederick Ruberg, MD
Thomas J. Ryan Professor of Cardiovascular Medicine
Chief, Cardiovascular Medicine
Professor of Radiology
Boston University Chobanian & Avedisian School of Medicine
Boston Medical Center
Boston, Massachusetts